{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T17:09:53Z","timestamp":1649178593717},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,4,14]],"date-time":"2010-04-14T00:00:00Z","timestamp":1271203200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s00115-009-2851-9","type":"journal-article","created":{"date-parts":[[2010,4,12]],"date-time":"2010-04-12T14:51:33Z","timestamp":1271083893000},"page":"539-548","source":"Crossref","is-referenced-by-count":4,"title":["Akut- und Langzeittherapie der bipolaren Depressionen"],"prefix":"10.1007","volume":"81","author":[{"given":"H.","family":"Grunze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Dargel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,14]]},"reference":[{"key":"2851_CR1","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1176\/appi.ajp.160.7.1252","volume":"160","author":"Altshuler","year":"2003","unstructured":"Altshuler L, Suppes T, Black D et al (2003) Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry 160:1252\u20131262","journal-title":"Am J Psychiatry"},{"key":"2851_CR2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0006-3223(03)00087-8","volume":"53","author":"Altshuler","year":"2003","unstructured":"Altshuler LL, Frye MA, Gitlin MJ (2003) Acceleration and augmentation strategies for treating bipolar depression. Biol Psychiatry 53:691\u2013700","journal-title":"Biol Psychiatry"},{"key":"2851_CR3","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.4088\/JCP.08m04191","volume":"70","author":"Altshuler","year":"2009","unstructured":"Altshuler LL, Post RM, Hellemann G et al (2009) Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study. J Clin Psychiatry 70(9):1273\u20131280","journal-title":"J Clin Psychiatry"},{"key":"2851_CR4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0165-0327(01)00377-9","volume":"68","author":"Angst","year":"2002","unstructured":"Angst F, Stassen HH, Clayton PJ, Angst J (2002) Mortality of patients with mood disorders: follow-up over 34\u201338 years. J Affect Disord 68:167\u2013181","journal-title":"J Affect Disord"},{"key":"2851_CR5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/sj.mp.4001647","volume":"10","author":"Bauer","year":"2005","unstructured":"Bauer M, London ED, Rasgon N et al (2005) Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Mol Psychiatry 10:456\u2013469","journal-title":"Mol Psychiatry"},{"key":"2851_CR6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4088\/JCP.v67n0108","volume":"67","author":"Bauer","year":"2006","unstructured":"Bauer MS, Wisniewski SR, Marangell LB et al (2006) Are antidepressants associated with new-onset suicidality in bipolar disorder? a prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry 67:48\u201355","journal-title":"J Clin Psychiatry"},{"key":"2851_CR7","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.4088\/JCP.v69n1009","volume":"69","author":"Bond","year":"2008","unstructured":"Bond DJ, Noronha MM, Kauer-Sant\u2019Anna M et al (2008) Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis. J Clin Psychiatry 69:1589\u20131601","journal-title":"J Clin Psychiatry"},{"key":"2851_CR8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archpsyc.57.5.481","volume":"57","author":"Bowden","year":"2000","unstructured":"Bowden CL, Calabrese JR, McElroy SL et al (2000) A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex maintenance study group. Arch Gen Psychiatry 57:481\u2013489","journal-title":"Arch Gen Psychiatry"},{"key":"2851_CR9","doi-asserted-by":"crossref","unstructured":"Brecher M, Anderssen H, Paulsson B (2008) Quetiapine in the maintenance treatment of Bipolar I disorder: Combined data from two long-term phase III studies. Bipolar Disord 10 [Suppl 1]:40","DOI":"10.1016\/j.eurpsy.2008.01.404"},{"key":"2851_CR10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00004850-198910000-00006","volume":"4","author":"Cohn","year":"1989","unstructured":"Cohn JB, Collins G, Ashbrook E, Wernicke JF (1989) A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 4:313\u2013322","journal-title":"Int Clin Psychopharmacol"},{"key":"2851_CR11","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/archpsyc.60.4.402","volume":"60","author":"Colom","year":"2003","unstructured":"Colom F, Vieta E, Martinez-Aran A et al (2003) A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry 60:402\u2013407","journal-title":"Arch Gen Psychiatry"},{"key":"2851_CR12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1192\/bjp.bp.107.040485","volume":"194","author":"Colom","year":"2009","unstructured":"Colom F, Vieta E, Sanchez-Moreno J et al (2009) Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial. Br J Psychiatry 194:260\u2013265","journal-title":"Br J Psychiatry"},{"key":"2851_CR13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4088\/JCP.v58n1102","volume":"58","author":"Denicoff","year":"1997","unstructured":"Denicoff KD, Smith-Jackson EE, Disney ER et al (1997) Comparative prophylactic efficacy of lithium, carbamazepine and the combination in bipolar disorder. J Clin Psychiatry 58:470\u2013478","journal-title":"J Clin Psychiatry"},{"key":"2851_CR14","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1176\/appi.ajp.2007.06060981","volume":"164","author":"Frye","year":"2007","unstructured":"Frye MA, Grunze H, Suppes T et al (2007) A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry 164:1242\u20131249","journal-title":"Am J Psychiatry"},{"key":"2851_CR15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.161.2.217","volume":"161","author":"Geddes","year":"2004","unstructured":"Geddes JR, Burgess S, Hawton K et al (2004) Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 161:217\u2013222","journal-title":"Am J Psychiatry"},{"key":"2851_CR16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bjp.bp.107.048504","volume":"194","author":"Geddes","year":"2009","unstructured":"Geddes JR, Calabrese JR, Goodwin GM (2009) Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry 194:4\u20139","journal-title":"Br J Psychiatry"},{"key":"2851_CR17","unstructured":"Geddes JR, The BALANCE investigators and collaborators (2010) Bipolar affective disorder: Lithium\/anti-convulsant evaluation (BALANCE) \u2013 an international, randomised, open-label trial of combination therapy in relapse prevention in bipolar disorder, type 1. Lancet (in press)"},{"key":"2851_CR18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1600-0447.2008.01257.x","volume":"118","author":"Ghaemi","year":"2008","unstructured":"Ghaemi SN, Wingo AP, Filkowski MA, Baldessarini RJ (2008) Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatr Scand 118:347\u2013356","journal-title":"Acta Psychiatr Scand"},{"key":"2851_CR19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1176\/ajp.129.1.44","volume":"129","author":"Goodwin","year":"1972","unstructured":"Goodwin FK, Murphy DL, Dunner DL, Bunney WE (1972) Lithium response in unipolar versus bipolar depression. Am J Psychiatry 129:44\u201347","journal-title":"Am J Psychiatry"},{"key":"2851_CR20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4088\/JCP.v65n0321","volume":"65","author":"Goodwin","year":"2004","unstructured":"Goodwin GM, Bowden CL, Calabrese JR et al (2004) A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 65:432\u2013441","journal-title":"J Clin Psychiatry"},{"key":"2851_CR21","unstructured":"Grunze H, Forsthoff A, Born C (2005) Polypharmazie in der Behandlung bipolarer St\u00f6rungen. In: Messer T, Schmauss M (Hrsg) Polypharmazie in der Behandlung psychischer Erkrankungen. Springer, Wien New York, S 81\u2013102"},{"key":"2851_CR22","doi-asserted-by":"crossref","unstructured":"Grunze H, Vieta E, Goodwin GM et al (2010) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry (in press)","DOI":"10.3109\/15622970903555881"},{"key":"2851_CR23","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/sj.npp.1300190","volume":"28","author":"Gyulai","year":"2003","unstructured":"Gyulai L, Bowden CL, McElroy SL et al (2003) Maintenance efficacy of divalproex in the prevention of bipolar depression. Neuropsychopharmacology 28:1374\u20131382","journal-title":"Neuropsychopharmacology"},{"key":"2851_CR24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4088\/JCP.v64n0206","volume":"64","author":"Hartong","year":"2003","unstructured":"Hartong EG, Moleman P, Hoogduin CA et al (2003) Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients. J Clin Psychiatry 64:144\u2013151","journal-title":"J Clin Psychiatry"},{"key":"2851_CR25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jad.2009.01.014","volume":"118","author":"Medda","year":"2009","unstructured":"Medda P, Perugi G, Zanello S et al (2009) Response to ECT in bipolar I, bipolar II and unipolar depression. J Affect Disord 118:55\u201359","journal-title":"J Affect Disord"},{"key":"2851_CR26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0165-0327(01)00449-9","volume":"67","author":"M\u00f6ller","year":"2001","unstructured":"M\u00f6ller HJ, Bottlender R, Grunze H et al (2001) Are antidepressants less effective in the acute treatment of bipolar I compared to unipolar depression? J Affect Disord 67:141\u2013146","journal-title":"J Affect Disord"},{"key":"2851_CR27","unstructured":"M\u00fcller-Oerlinghausen B, Ahrens B, Felber W (2006) The suicide-preventive and mortality reducing effect of lithium. In: Bauer M, Grof P, M\u00fcller-Oerlinghausen B (eds) Lithium in neuropsychiatry: The comprehensive guide. Informa healthcare, Oxfordshire, UK, pp 179\u2013192"},{"key":"2851_CR28","doi-asserted-by":"crossref","unstructured":"M\u00fcller-Oerlinghausen B, Greil W, Bergh\u00f6fer A (1997) Die Lithiumtherapie: Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg","DOI":"10.1007\/978-3-642-60819-3"},{"key":"2851_CR29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1176\/appi.ajp.163.2.210","volume":"163","author":"Nierenberg","year":"2006","unstructured":"Nierenberg AA, Ostacher MJ, Calabrese JR et al (2006) Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry 163:210\u2013216","journal-title":"Am J Psychiatry"},{"key":"2851_CR30","doi-asserted-by":"crossref","unstructured":"Nolen WA, Weisler RH, Neijber A et al (2009) Quetiapine or lithium versus placebo for maintenance treatment of bipolar I disorder after stabilization on quetiapine. Presented at the 17th European congress of psychiatry, 24\u201328 January 2009, Lisbon, Portugal","DOI":"10.1016\/S0924-9338(09)70828-4"},{"key":"2851_CR31","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa064135","volume":"356","author":"Sachs","year":"2007","unstructured":"Sachs GS, Nierenberg AA, Calabrese JR et al (2007) Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 356:1711\u20131722","journal-title":"N Engl J Med"},{"key":"2851_CR32","doi-asserted-by":"crossref","unstructured":"Sartorius N, Baghai TC, Baldwin DS et al (2007) Antidepressant medications and other treatments of depressive disorders: a CINP Task force report based on a review of evidence. Int J Neuropsychopharmacol 10 [Suppl 1]:1\u2013207","DOI":"10.1017\/S1461145707008255"},{"key":"2851_CR33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1399-5618.2007.00475.x","volume":"10","author":"Severus","year":"2008","unstructured":"Severus WE, Kleindienst N, Seemuller F et al (2008) What is the optimal serum lithium level in the long-term treatment of bipolar disorder\u2013a review? Bipolar Disord 10:231\u2013237","journal-title":"Bipolar Disord"},{"key":"2851_CR34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/YCT.0b013e3180330059","volume":"23","author":"Sienaert","year":"2007","unstructured":"Sienaert P, Peuskens J (2007) Anticonvulsants during electroconvulsive therapy: review and recommendations. J ECT 23:120\u2013123","journal-title":"J ECT"},{"key":"2851_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2009.10.033","volume":"122","author":"Smith","year":"2009","unstructured":"Smith LA, Cornelius VR, Azorin JM et al (2009) Valproate for the treatment of acute bipolar depression: Systematic review and meta-analysis. J Affect Disord 122(1):1","journal-title":"J Affect Disord"},{"key":"2851_CR36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00004714-199802000-00007","volume":"18","author":"Solomon","year":"1998","unstructured":"Solomon DA, Keitner GI, Ryan CE, Miller IW (1998) Lithium plus valproate as maintenance polypharmacy for patients with bipolar I disorder: a review. J Clin Psychopharmacol 18:38\u201349","journal-title":"J Clin Psychopharmacol"},{"key":"2851_CR37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2165\/00003088-199631030-00004","volume":"31","author":"Spina","year":"1996","unstructured":"Spina E, Pisani F, Perucca E (1996) Clinically significant pharmacokinetic drug interactions with carbamazepine. An update. Clin Pharmacokinet 31:198\u2013214","journal-title":"Clin Pharmacokinet"},{"key":"2851_CR38","doi-asserted-by":"crossref","first-page":"b2880","DOI":"10.1136\/bmj.b2880","volume":"339","author":"Stone","year":"2009","unstructured":"Stone M, Laughren T, Jones ML et al (2009) Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ 339:b2880","journal-title":"BMJ"},{"key":"2851_CR39","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","volume":"374","author":"Tiihonen","year":"2009","unstructured":"Tiihonen J, Lonnqvist J, Wahlbeck K et al (2009) 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 374:620\u2013627","journal-title":"Lancet"},{"key":"2851_CR40","doi-asserted-by":"crossref","unstructured":"Tohen M, Frank E, Bowden CL et al (2010) The International Society of Bipolar Disorders (ISBD) task force on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord (in press)","DOI":"10.1016\/j.jad.2010.01.030"},{"key":"2851_CR41","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","volume":"60","author":"Tohen","year":"2003","unstructured":"Tohen M, Vieta E, Calabrese J et al (2003) Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 60:1079\u20131088","journal-title":"Arch Gen Psychiatry"},{"key":"2851_CR42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4088\/JCP.08m04152","volume":"70","author":"Loos","year":"2009","unstructured":"Loos ML van der, Mulder PG, Hartong EG et al (2009) Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. J Clin Psychiatry 70:223\u2013231","journal-title":"J Clin Psychiatry"},{"key":"2851_CR43","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.biopsych.2009.02.018","volume":"66","author":"Wu","year":"2009","unstructured":"Wu JC, Kelsoe JR, Schachat C et al (2009) Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder. Biol Psychiatry 66(3):298\u2013301","journal-title":"Biol Psychiatry"},{"key":"2851_CR44","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jpsychires.2005.06.002","volume":"41","author":"Zhang","year":"2007","unstructured":"Zhang ZJ, Kang WH, Tan QR et al (2007) Adjunctive herbal medicine with carbamazepine for bipolar disorders: A double-blind, randomized, placebo-controlled study. J Psychiatr Res 41:360\u2013369","journal-title":"J Psychiatr Res"},{"key":"2851_CR45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00004714-199312000-00005","volume":"13","author":"Zornberg","year":"1993","unstructured":"Zornberg GL, Pope HG (1993) Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol 13:397\u2013408","journal-title":"J Clin Psychopharmacol"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-009-2851-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-009-2851-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-009-2851-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T05:43:00Z","timestamp":1559022180000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-009-2851-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,14]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["2851"],"URL":"https:\/\/doi.org\/10.1007\/s00115-009-2851-9","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,14]]}}}